As the latest, more contagious subvariant of omicron makes its way across the country, Coloradans are left to wonder when XBB.1.5 (better known as kraken) will arrive in Colorado, if getting the newest booster will protect them against it, and what’s on the horizon for additional vaccines.
Focused on warding off a cold-weather surge of coronavirus infections and on revamping the COVID-19 vaccine response, health experts approved a new and likely improved version of the vaccine for the first time since the virus emerged.
As medical researchers dig for answers behind Long COVID, unexplained liver disease in children and unusual behaviors of common respiratory viruses including influenza, a rollout of a COVID-19 vaccine for the country’s youngest age group is underway.
Americans 50 and older who are four months post-booster shot received the green light last week for COVID booster No. 2. An unexpected age drop combined with a receding threat of infection have some people in the approved group asking questions before rolling up their sleeves for a fourth time.
Research COVID-19 Cancer Vaccine
Much has changed in the world since COVID-19 emerged and touched off a global health crisis. The University of Colorado Anschutz Medical Campus and other academic research institutions have been at the heart of the response to the pandemic, aggregating data, making discoveries, running clinical trials and developing therapies.
Laura Kelley
